At the end of 2023, the FDA announced the creation of a digital health advisory committee, which will help the agency better understand the risks and benefits of emerging health care technology such as artificial intelligence and virtual reality.
This Advisory Committee will advise the FDA on a wide range of technologies such as artificial intelligence and machine learning, virtual reality, or wearables; and issues such as decentralized clinical trials, patient generated health data, or cybersecurity.
Recent Posts
The Perfect Blend of Professional and Personal
AAA 2026 is coming to San Antonio—right in the middle of Fiesta, one of the city’s most vibrant celebrations. This year, it’s easier than ever…
CMS Sets Medically Unlikely Edit for Key Audiology Codes
The Centers for Medicare and Medicaid Services (CMS) has established a Medically Unlikely Edit (MUE) of two units per date of service for Current Procedural Terminology (CPT®) codes 92629, 92632,…
Allergies in U.S. Adults
Individuals who live in colder areas of the country may be eagerly awaiting the arrival of spring and its associated warmer weather. Others may be…


